156 related articles for article (PubMed ID: 5316651)
1. [Clinical evaluation of Cinnarizine in patients with peripheral vascular diseases].
Simões Neto E
Hospital (Rio J); 1971 Jan; 79(1):189-98. PubMed ID: 5316651
[No Abstract] [Full Text] [Related]
2. [Flunarizine in patients with inadequate cerebral and peripheral circulation. Multicentric double blind study].
Domschky K; Nelson M; Dammhayn B; Terjung E
Med Welt; 1977 Jun; 28(23):1062-4. PubMed ID: 886963
[No Abstract] [Full Text] [Related]
3. [Action of MD 1035 in peripheral vascular manifestations].
Barraine R; Efthymiou TP; Marcantoni JP
Presse Med (1893); 1970 Dec; 78(53):2389-90. PubMed ID: 5489156
[No Abstract] [Full Text] [Related]
4. [Clinical trial of cinnarizine in some vascular diseases].
Triandaf I; Cosma M; Triandaf N
Rev Med Chir Soc Med Nat Iasi; 1976; 80(1):19-22. PubMed ID: 135327
[No Abstract] [Full Text] [Related]
5. Preliminary results in the treatment of peripheral arteriopathies with a new pharmacologic substance: I-(2"pyrimidyl)4 piperonyl piperazine (ET 495).
Royer RJ
Bibl Cardiol; 1969; 26():174-9. PubMed ID: 5402343
[No Abstract] [Full Text] [Related]
6. [Effects of nicergoline in peripheral arteriopathies of the lower limbs. Double-blind study].
Coscia M
Minerva Cardioangiol; 1972 Sep; 20(9):497-504. PubMed ID: 4561065
[No Abstract] [Full Text] [Related]
7. [Evaluation of dioxylline phosphate in vascular diseases. Clinical results].
Rodari T; Tirella G
Clin Ter; 1972 Jul; 62(1):53-7. PubMed ID: 5071748
[No Abstract] [Full Text] [Related]
8. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases].
De Gregorio G; Restivo S
Clin Ter; 1982 Dec; 103(5):501-7. PubMed ID: 7160142
[No Abstract] [Full Text] [Related]
9. Clinical evaluation of cinnarizine in patients with cerebral circulatory deficiency.
Toledo JB; Pisa H; Marchese M
Arzneimittelforschung; 1972 Feb; 22(2):448-51. PubMed ID: 4554633
[No Abstract] [Full Text] [Related]
10. Cinnarizine in peripheral vascular insufficiency. Studies on blood flow, muscle capacity, and vascular tone.
Schuermans V; Boermans A; Geivers H; Jageneau A; Brugmans J
Arzneimittelforschung; 1971 Oct; 21(10):1541-3. PubMed ID: 5171882
[No Abstract] [Full Text] [Related]
11. [Rheologic therapy of peripheral arteriopathies. Personal observations on the use of flunarizin].
Palleschi M; Marci M; Ceraso C; Passacantilli A; Marin P
Clin Ter; 1984 Aug; 110(3):215-20. PubMed ID: 6237860
[No Abstract] [Full Text] [Related]
12. Peripheral vascular disease: cinnarizine et al.
Drug Ther Bull; 1981 Mar; 19(7):27-8. PubMed ID: 7227205
[No Abstract] [Full Text] [Related]
13. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
Ambrosi V; Gabrielli F
Minerva Med; 1983 Mar; 74(13):685-9. PubMed ID: 6220230
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of peripheral vascular disorders with dilatol].
Knapik Z; Twardzicki J; Wlodarczykowa J
Pol Tyg Lek; 1965 Jun; 20(23):846-8. PubMed ID: 5841123
[No Abstract] [Full Text] [Related]
15. Responsiveness of various symptoms of vascular disorders to calcium antagonist.
Verhaegen H; Reyntjens A; Horig C; Pötsch W
Angiology; 1979 Jul; 30(7):447-53. PubMed ID: 380409
[No Abstract] [Full Text] [Related]
16. [Clinical considerations on the use of a drug with vasodilating hemokinetic action in cerebral and peripheral vascular diseases].
Florio F; Ruffolo S; Piro E
Minerva Cardioangiol; 1976 Feb; 24(2):161-70. PubMed ID: 1256656
[No Abstract] [Full Text] [Related]
17. [Our experience in the treatment of peripheral vascular diseases with raubasine].
Vercellio G; Costantini S; Giulini S
Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726
[No Abstract] [Full Text] [Related]
18. [Relationship between blood flow values of the upper and the lower extremities and effects of a vasoactive agent in persons with normal circulation and patients with vascular diseases].
Caesar K
Med Welt; 1971 Apr; 14():559-62. PubMed ID: 5551942
[No Abstract] [Full Text] [Related]
19. [Clinical results in therapy of peripheral vascular diseases with ginkgo-biloba].
Bartolo M
Minerva Med; 1973 Nov; 64(79 Suppl):4187-93. PubMed ID: 4592295
[No Abstract] [Full Text] [Related]
20. [Clinical experiences with a new vasodilator: 3-(methylhydroxyethylamino)-2-hydroxypropyltheophylline nicotinate].
Sideri GC; Fumagalli G; Locatelli R
Arch Patol Clin Med; 1965 Jun; 41(6):479-83. PubMed ID: 5319767
[No Abstract] [Full Text] [Related]
[Next] [New Search]
